Introduction
The HIV-1 population found in acute infections is very homogeneous, in contrast to the high diversity of the quasispecies observed in chronic infections [1, 2] . Several studies concluded that sexual transmission of HIV-1 involves a genetic bottleneck, resulting in the transmission of a single or limited number of viral variants [2] [3] [4] [5] [6] [7] [8] .
Substantial efforts have been made to identify properties that differ between transmitted/founder (T/F) and chronic viruses. However, many findings are inconsistent. T/F viruses from subtypes A, C, and D appear to carry shorter and less glycosylated envelope glycoproteins (Env) [1, 9, 10] , but this trend was not observed in subtype B viruses [5, 11, 12] . Clade B T/F viruses were reported to be more sensitive to neutralizing antibodies (NAbs) that target the CD4 þ -binding site [12] , but this was not observed for subtype C viruses [10] . On the other hand, subtype C T/F viruses were found to be more sensitive to antibodies obtained from their infecting donor [1] , but this was not observed in a subtype B cohort [11] . Several studies have shown that almost all T/F viruses use the CCR5 coreceptor and require high levels of CD4
þ to infect cells [3, 10, [13] [14] [15] [16] , even if T/F viruses appear to be more restricted in the use of various CCR5 conformations than chronic viruses [10, 17] . Recent articles suggested that dendritic cells or immature Langerhans cells mediate the selective transmission of CCR5-using viruses during their penetration through the mucous membrane barriers [18, 19] . T/F viruses appear also to be modestly more resistant to the fusion inhibitor T1249 than chronic viruses [3] , but this was not observed using the fusion inhibitor enfuvirtide (T20) [20] . T/F viruses were reported to display enhanced binding to dendritic cells and to subsequently be more efficiently transferred to T cells than viruses derived from chronic infections [21] , but this was not observed in another study [12] . It was also shown that T/F viruses exhibit enhanced infectious properties [21, 22] , but this trend was not observed in other studies [5, 23] . Finally, it was suggested that the innate immune system, through type I interferons, may favor the selection of interferon a (IFNa)-resistant viruses during transmission [21, 22, 24, 25] . In contrast, other studies showed that T/F viruses were equally [23] or modestly more [5] sensitive to IFN-a than their linked donor isolates.
Overall, except for CCR5 utilization, no phenotypic features are consistently linked to the transmitted variant. Conflicting findings may originate from differences in methodologies and/or study populations. Indeed, some studies examined only a limited number of transmission pairs using samples issued from the chronically infected donor and its linked receiver, whereas others used large sequence data sets of unlinked acutely infected persons versus chronically infected patients. However, we cannot exclude that stochastic effects may also contribute to the transmission bottleneck and that any sufficiently fit R5 virus might be transmitted.
To better understand whether the transmission bottleneck is mainly stochastic or if viral variants with particular biological properties are selected at transmission, we used another approach based on the comparison of the antigenic and functional properties of transmitted viruses that have a common origin, derived from eight transmission clusters. We hypothesized that, if the transmitted variants within a transmission cluster have a selective advantage, they should share some phenotypic characteristics. Moreover, if some properties are conserved between all the variants irrespective of the cluster to which they belong, they should favor their transmission.
Methods

Study population
The HIV-1 population was derived from plasma samples collected at time of or very early after primary infection from patients enrolled in the ANRS PRIMO cohort [26] . The patients were 27 Caucasian MSM, infected by clade B (six clusters, 21 patients) or CRF02-AG (two clusters, six patients) viruses between 2006 and 2013 (Supplemental Table 1 , http://links.lww.com/QAD/B314). They segregated into eight transmission clusters identified by strong similarity of the pol gene (genetic distance <0.015%) and phylogenetic analyses (bootstrap of the cluster >98%) [27] . All patients were antiretroviral-naive at the time of enrollment in the cohort. The estimated date of infection was defined as the date of symptom onset minus 15 days for patients with symptomatic primary infection, or, for asymptomatic patients, the date of the incomplete western blot (presence of antibodies to gp160 and P24) minus 1 month or the midpoint between a negative and a positive ELISA result [26] . National ethics committee approvals were obtained for the cohort [Comit e Consultatif de Protection des Personnes dans la Recherche Biom edicale (CCPPRB) Paris-Cochin and Comit e de Protection des Personnes (CPP) Ile de France III] and all patients gave written informed consent to participate in the cohort.
Production of pseudotyped viruses, titration, and analysis of their envelope glycoprotein content Env-pseudotyped viruses were produced as described previously [28] . For the analysis of the Env content, viral particles were overlaid on a 20% sucrose cushion and pelleted at 87 000 Â g for 1.5 h at 4 8C. Viral pellets were solubilized overnight at 4 8C in 100 ml PBS supplemented with 1% Triton X-100 and an antiprotease cocktail. P24 antigen content was determined by ELISA (INNOTEST HIV Antigen mAb; Innogenetics, Gent, Belgium). The Env ELISA was performed in Nunc Maxisorp plates (Dutscher, Brumath, France). A pool of three HuMoNAbs (PGT145, b12, PGT128) was used for the detection of Env captured on D7324 (Aalto Bioreagents Ltd., Dublin, Ireland)-coated microplates. Dilutions of purified gp120IIIB (Advanced Bioscience Laboratories, Illkirch-Graffenstaden, France) were used to construct a standard curve.
Viral infectivity in TZM-bl cells Viral infectivity was determined in quadruplicate in TZM-bl cells. Samples of 100 ml virus stock, normalized to 25 ng P24 were added to 100 ml culture medium. Aliquots of 1 Â 10 4 TZM-bl cells were added to viruses in the presence of 30 mg/ml DEAE-dextran. Infection levels were determined after 48 h by measuring the luciferase activity of cell lysates using the Bright-Glo luciferase assay (Promega, Charbonnières-les-bains, France) and a Centro LB 960 luminometer (Berthold Technologies, Thoiry, France).
Neutralization assay
The sensitivity to neutralization of pseudotyped viruses was probed in TZM-bl cells using HuMoNAbs PG9, PGT145, NIH45-46 G54W , 3BNC117, 10-1074, PGT121, 10E8, and 8ANC195 (IAVI and NIH AIDS Reagent Program), as described previously [28] .
Determination of co-receptor usage Co-receptor usage was determined using U373 MAGI cells (NIH AIDS Reagent Program) stably expressing CD4 þ and either CCR5 or CXCR4, as described previously [29] .
Inhibition of entry by enfuvitide, CCR5 antagonists, and CD4
R analogs TZM-bl cells were used in duplicate to assess the sensitivity of pseudotyped viruses to the fusion inhibitor T20, CCR5 antagonist MVC, and CD4 þ inhibitors sCD4, sCD4-183 (NIH AIDS Reagent Program), and M48U1 (provided by L. Martin, CEA, Gif sur Yvette, France). After titration, pseudotyped virus stocks were diluted to obtain 400 TCID 50 /ml in growth medium. Aliquots of 50 ml were then incubated for 1 h at 37 8C with 50 ml of three-fold serial dilutions of T20, sCD4, sCD4-183, or M48U1 (10-0.0046 mg/ml). The virusinhibitor mixture was then used to infect 1 Â 10 4 TZM-bl cells in the presence of 30 mg/ml DEAEdextran. Infection levels were determined after 48 h by measuring the luciferase activities of cell lysates. IC 50 values were defined as the inhibitor concentration reducing RLUs by 50%. Results were expressed as mean duplicate values.
For MVC inhibition, 8 Â 10 3 TZM-bl cells per well were plated the day before infection. Cells were first treated for 1 h at 37 8C with 150 ml three-fold serial dilutions of MVC (6 mmol/l to 0.3 nmol/l) before adding 50 ml pseudotyped viruses normalized to 400 TCID 50 /ml. One hundred microliters DMEM medium, supplemented with 30 mg/ml DEAE-dextran, was then added to the cells. Luciferase activity was measured 48 h after infection as described above. CCR5 antagonist susceptibility is expressed as the maximal percentage inhibition (MPI) and IC 50 values.
Sanger sequence analysis
All full-length env PCR products were sequenced according to the Dye Terminator cycle sequencing protocol (Applied Biosystems, Foster City, California, USA). All sequences have been submitted to GenBank and assigned accession numbers MH000288 to MH000314. Nucleotide sequences were aligned using CLUSTALW and manually edited. Potential N-linked glycosylation sites (PNGS) were identified using the N-Glycosite tool at the HIV LANL database website (http://www.hiv.lanl.gov). A maximum likelihood tree was computed with RAxML, using the GTRGAMMA model of nucleotide substitutions with bootstrap analysis to assess branch support (1000 replicates). We conducted a BLAST search to identify the 10 most closely related sequences available in GenBank for each sequence. After excluding duplicate sequences, these sequences were downloaded and included in the phylogenetic analysis. Mean intra-cluster p-distances, that is, the proportion of nucleotide differences between two sequences in a cluster, were calculated using MEGA7.
Results
Studied population
Blood samples of selected patients were collected less than 3 months postinfection. The variants that we analyzed were, therefore, considered to be early/transmitted viruses. The maximum window periods for transmission after primary infection were estimated by determining the time interval between the first and last infection within each cluster (Supplemental Table 1 , http://links. lww.com/QAD/B314). Transmission intervals ranged from 0.4 to 37.6 months, with a median transmission interval of 17.1 months (IQR 5-35.5).
Comparison of nucleotidic env and deduced amino-acid envelope glycoprotein sequences Full length env sequences of the transmitted viral population infecting each patient were obtained by sequencing of bulk env PCR products. We compared the 27 sequences to the 140 most closely related env sequences available in GenBank. Phylogenetic analyses confirmed that the env sequences from the selected patients grouped into eight clusters (bootstrap value of 100%), including six clusters of subtype B and two clusters of CRF02-AG env sequences. Within each cluster, the mean p-distance was low, ranging from 0.005 to 0.093 nucleotide substitutions per site (Fig. 1 ).
As it was previously suggested that short length and low number of PNGS of gp120 variable regions were characteristics of T/F viruses [1, 9, 10] , we looked at them in our 27 Env sequences (Table 1) . Both length and number of PNGS differed between clusters. Surprisingly, although variants within each cluster were genetically closely related, a substantial diversity in length and number of PNGS of the variable regions was observed, except for the V3 region. Only variants of cluster 8 were highly homogeneous, with equal length, net charge, and PNGS for each variable region. Of note, the time interval between the first and last infection within this cluster was extremely short (11 days) (Supplemental Table 1 , http:// links.lww.com/QAD/B314).
Transmitted viruses belonging to the same cluster have similar neutralization profiles We generated pseudotyped viruses expressing Env variants representative of the viral quasispecies infecting each patient and compared their sensitivity to neutralization by a panel of eight HuMoNAbs chosen to be representative of the five regions of vulnerability of the HIV-1 envelope [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] (Fig. 2) . Neutralization profiles were highly conserved within each cluster except for viruses of cluster 6, suggesting the transmission of variants with specific properties, even when the transmission events occurred at several months' interval. Viruses of cluster 6 differed from those of other clusters by their high resistance to almost all HuMoNAbs. Disregarding variants of cluster 6, all transmitted viruses were susceptible to antibodies targeting V3, the CD4 þ -binding site, and the membrane-proximal external region (MPER), suggesting the transmission of viruses harboring these epitopes. The neutralization profiles, although similar within each cluster, were different between clusters. This observation suggests a conservation of specific properties within each cluster for the viruses to be transmitted, but conservations that can be different for each transmission chain.
Inspection of HuMoNAb epitopes on Env sequences showed that most resistant viruses harbored mutations of essential residues (Supplemental Fig. 1 , http://links.lww.-com/QAD/B314). We observed a shift of the PNGS from N332 to N334 in all viruses of cluster 6 resistant to antibodies targeting V3 (Supplemental Fig. 1A , http:// links.lww.com/QAD/B314), a shift of the PNGS from N234 to N230 in viruses of clusters 3, 4, and 6, resistant to 8ANC195 (Supplemental Fig. 1B , http://links.lww.-com/QAD/B314), and the loss of N160 in viruses of clusters 6 and 7 that were resistant to both PG9 and PGT145 (Supplemental Fig. 1C , http://links.lww.com/ QAD/B314). We did not find any potential relationship between the resistance of viruses to antibodies targeting the CD4 þ -binding site and MPER region and the absence of specific residues at key positions. Table 2 , http://links.lww.com/QAD/B314).
We then assessed the efficiency of CCR5 usage of Envpseudotypes by infecting TZM-bl cells in the presence of decreasing concentrations of the CCR5 antagonist maraviroc (MVC) (6000-0.3 nmol/l). All pseudotyped viruses were highly susceptible to MVC with an IC 50 less than 10 nmol/l and maximal percentage inhibition (MPI) values above 90% in the presence of saturating concentrations of MVC (Fig. 3) .
Transmitted viruses are resistant to soluble CD4
R but sensitive to a CD4 R -mimetic miniprotein We compared the efficiency of CD4 þ receptor usage of all pseudotyped viruses through their sensitivity to CD4 þ analogs. Most viruses were highly resistant to two soluble forms of CD4 þ containing either all four (sCD4) or the first two (sCD4-183) extracellular domains, with IC 50 values greater than 10 mg/ml for 21 and 23 of 27 viruses, respectively (Fig. 3) . In contrast, all pseudotyped viruses, except one variant of cluster 6, were sensitive to M48U1, a CD4 þ -mimetic miniprotein [46, 47] (Fig. 3) .
We compared residues of the Phe-43 cavity and those known to interact with CD4 þ and/or M48U1 in the 27 Env sequences to identify potential molecular determinants of these differences (supplementary Figure 2 , http://links.lww.com/QAD/B314) [32, [46] [47] [48] [49] . There were no significant differences between viruses resistant or sensitive to the two soluble forms of CD4 þ . Comparison of the residues that interact with M48U1 showed that the only resistant virus (virus 275 of cluster 6) harbored a mutation of the conserved serine/threonine residue at position 375 to an isoleucine residue. The loss of this residue has already been described to disrupt the molecular interaction with M48U1 [47, 50, 51] .
Transmitted viruses are sensitive to the fusion inhibitor enfuvirtide
We tested Env-pseudotyped viruses for their sensitivity to T20. By mimicking the activity of HR2, T20 binds to the HR1 domain of gp41, which becomes exposed after CD4 þ /coreceptor engagement. Higher resistance to this fusion inhibitor may, thus reflect faster fusion kinetics. All viruses were sensitive to T20 (IC 50 <0.00457-1.23 mg/ml), with conserved sensitivity levels within each transmission cluster (Fig. 3) .
Transmitted viruses have similar infectious properties
We compared the capacity of pseudotyped viruses to infect TZM-bl cells in a single round of infection. Infectivity levels of each pseudotyped virus, for which the input was normalized to the amount of P24, was evaluated 48 h postinfection by measuring luciferase activity [relative luminescence unit (RLU)]. Infectivity levels were conserved within clusters, with a relative standard deviation (RSD) of log 10 RLU less than 15% for almost all clusters (Table 2 ). Only two clusters (clusters 2 and 6) displayed higher variability of infectivity levels (RSD of log 10 RLU >15%). Infectivity levels were also conserved between clusters, with log 10 RLU means ranging from 5.59 to 6.65 and a global RSD of 10.71% for the 27 viruses. As Env incorporation may be variable among the pseudotyped viruses, we determined the gp120 content of each viral stock and we assessed the infectivity after normalization for Env content. The four viruses of cluster 6 and one virus (virus 256) of cluster 2 harbored very low levels of gp120, under the detection limit of the ELISA test (Table 2) . Except for these five viruses, we evaluated the infectivity of each pseudotyped virus normalized for Env content by dividing infectivity values by gp120 content. Infectivity levels were again conserved, both within (RSD of log 10 RLU <10%) and between clusters (global RSD of 7.39% for the 22 viruses for which the infectivity values could be normalized) ( Table 2) . Overall, these results show that transmitted viruses had similar infectious properties.
Discussion
Previous studies have shown that generally a single HIV-1 variant from the diverse viral population in the transmitting partner establishes infection in the new host [2, 3, 5] . HIV-1 is clearly subjected to a stringent genetic bottleneck during transmission, but the extent to which this event is driven by specific properties of the transmitted viruses or is the result of a stochastic process remains to be determined. We analyzed the antigenic and functional properties of envelope glycoproteins of viral variants present during or very early after primary infection in 27 patients belonging to eight transmission chains of at least three patients to better understand this phenomenon. Our strategy was based on the assumption that, if transmitted viruses share properties within a transmission chain, these would be indicative of a nonstochastic process and, if properties are conserved both within and between transmission clusters, these would reflect a selective advantage.
Sequencing and phylogenetic analysis of env genes confirmed the close relation between viruses from a same transmission cluster. A detailed comparison of deduced Env amino-acid sequences revealed that the V1, V2, V4, and V5 regions differed in length, number of PNGS, and charge, despite the fact that the sequences were closely related within each cluster. Thus, transmitted variants, albeit closely related, differed between patients of the same transmission chain. Although we could assume that the viruses belonged to a same transmission chain based on molecular evidences, a comparison of transmitted variants with viral populations circulating in the chronic phase of infection could not be done because almost patients were treated within a few months after their inclusion in the cohort. In addition, we did not have epidemiological data suggesting that there were direct links such as donor/receiver pairs within them. It can be hypothesized that some transmission events might have emerged from other individuals belonging to the chain, including chronically infected patients harboring a diversified viral population. This is supported by studies on MSM cohorts from different countries that estimated that only approximately 25% of transmissions occurred during the first 6 months of infection [52] [53] [54] .
We analyzed the antigenic profiles of the transmitted Env variants by measuring their sensitivity to a panel of representative HuMoNAbs targeting the five regions of vulnerability of the HIV-1 envelope. Although the transmitted variants were not identical, they shared similar profiles. Neutralization profiles were highly conserved within all but cluster 6, regardless of the HuMoNAb, suggesting that the transmission bottleneck is mainly driven by a nonstochastic process. In addition, disregarding viruses of cluster 6, all transmitted viruses were susceptible to antibodies targeting V3, the CD4 þ -binding site, and the MPER region, strongly suggesting the transmission of viruses harboring these epitopes. These results are in accordance with our previous study showing that the best combination of HuMoNAbs to efficiently neutralize recently transmitted viruses of subtype B was that targeting these three regions [55] . These HuMoNAbs should, therefore, be good candidates to limit HIV transmission in prophylactic approaches or vaccine strategies. However, a variant such that present in cluster 6 would be susceptible to escape to prophylaxis with this tri-specific combination. This observation, in addition to the fact that the HIV-1 species seems to evolve toward higher resistance to neutralization [28, [55] [56] [57] , argues for a global prospective surveillance of the susceptibility of HIV-1 to HuMoNAbs.
We explored the functional properties of the transmitted viruses by next comparing their sensitivity to various entry inhibitors, including the MVC CCR5 antagonist, several CD4 þ analogs, and the T20 fusion inhibitor. All viruses were CCR5-tropic and highly susceptible to MVC, suggesting that transmitted viruses are restricted to use CCR5 conformations that are sensitive to MVC. This result is in accordance with previous studies showing that transmitted viruses are less able to use a MVC-resistant form of CCR5 than viral variants found during chronic infections [10, 17] . Although the biological significance of this phenomenon remains to be determined, it appears that the transmission bottleneck selects for viruses that are restricted in the use of the CCR5 co-receptor. Analysis of the sensitivity of transmitted viruses to two soluble forms of CD4 þ (sCD4 and sCD4-183) showed that most viruses were highly resistant to both forms (IC 50 >10 mg/ml), suggesting that their affinity for CD4 þ is low and consequently that they may require high levels of CD4 þ to efficiently infect target cells. In agreement with our results, several studies have shown that transmitted viruses are unable to efficiently infect cells expressing low levels of CD4
þ [14, 15, 58, 59] . In contrast, all viruses were highly sensitive to M48U1. The difference in response to exposure to either soluble forms of CD4 þ or M48U1 could be explained by the fact that M48U1 binds to gp120 with higher affinity than that of the CD4 þ protein [46, 60] . This property is because of the presence of flexible hydrophobic extensions that fit into and stabilize the Phe-43 cavity, a critical element in the interaction between gp120 and CD4 þ . Our result reinforces the potential use of M48U1 as a new microbicide to prevent HIV-1 transmission [61] . Viruses were also highly sensitive to the fusion inhibitor T20, with conserved sensitivity levels within each cluster reinforcing the hypothesis that the transmission bottleneck is a nonstochastic event.
We also analyzed the infectivity of transmitted viruses in a single round of infection of TZM-bl cells. Except for a few viruses, transmitted viruses shared similar infectious properties, regardless of whether the input normalization was based on P24 or Env incorporation levels. Infectivity levels were in the same range as those of regularly used laboratory strains, NL4-3 or AD8, suggesting that the transmission bottleneck did not select for particularly highly infectious Env variants.
In conclusion, our study shows that transmitted viruses from the same transmission chain share similar phenotypic properties. It is impressive to see that viruses from a same cluster have similar neutralization profiles and sensitivity to various inhibitors, even when viruses are transmitted at several months or years interval and possibly after passages through various intermediate hosts. It suggests that the conservation of biological properties for a given variant to be successfully transmitted is a necessity. It seems to us that this phenomenon is a strong argument to suggest that the transmission bottleneck is mainly nonstochastic but involves specific properties conferring a selective advantage. In addition, some properties were conserved between all viruses, regardless of the cluster they belong. They were CCR5-tropic, sensitive to MVC, and resistant to soluble forms of CD4 þ , reinforcing previous studies showing the restrictive use of CCR5 and the requirement of high levels of CD4 þ of transmitted viruses. They were also sensitive to HuMoNAbs targeting V3, the CD4 þ -binding site, and the MPER region, suggesting that the loss of these functionally important regions might compromise their fitness and transmission capacity. Taken together, our results argue for the necessity for a variant to harbor specific phenotypic properties to be able to be transmitted. 
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